Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
25.36
+0.89 (3.64%)
May 13, 2025, 4:10 PM AEST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Precision Medicine
771.11M
Log In
Log In
Log In
Log In
Therapeutics
9.35M
Log In
Log In
Log In
Log In
Manufacturing Solutions
2.75M
Log In
Log In
Log In
Log In
Commercial
-
Log In
Log In
Log In
Log In
Commercial Growth
-
Log In
Log In
Log In
Log In
Product Development
-
Log In
Log In
Log In
Log In
Product Development Growth
-
Log In
Log In
Log In
Log In
Molecularly Targeted Radiation
-
Log In
Log In
Log In
Log In
Molecularly Targeted Radiation Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
762.31M
Log In
Log In
Log In
Log In
United States Growth
55.68%
Log In
Log In
Log In
Log In
Other Countries
16.01M
Log In
Log In
Log In
Log In
Other Countries Growth
242.94%
Log In
Log In
Log In
Log In
Canada
2.54M
Log In
Log In
Log In
Log In
Australia
1.22M
Log In
Log In
Log In
Log In
Australia Growth
4.63%
Log In
Log In
Log In
Log In
United Kingdom
579.00K
Log In
Log In
Log In
Log In
United Kingdom Growth
-55.67%
Log In
Log In
Log In
Log In
Belgium
546.00K
Log In
Log In
Log In
Log In
Belgium Growth
19.21%
Log In
Log In
Log In
Log In
China
-
Log In
Log In
Log In
Log In
China Growth
-
Log In
Log In
Log In
Log In
Austria
-
Log In
Log In
Log In
Log In
Australia, United States, Belgium and Japan
-
Log In
Log In
Log In
Log In
Australia, United States, Belgium and Japan Growth
-
Log In
Log In
Log In
Log In